Neurizon has filed an Investigational New Drug application with the US FDA for lead drug candidate NUZ-001 to treat ...
Pending FDA clearance of the IND application, Neurizon anticipates Massachusetts General Hospital (MGH) filing a protocol amendment to their IND for the HEALEY ALS Platform Trial to incorporate our ...